Cargando…

Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer

A 66-year-old woman underwent partial mastectomy and a sentinel lymph node biopsy for left breast cancer; the pathological diagnosis was invasive ductal carcinoma (pT1aN0, pStage I, triple-negative subtype). Postoperative radiotherapy was performed. Two years later, she developed redness and indurat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawaguchi, Yuta, Kuba, Sayaka, Morita, Michi, Meng, Xiangyue, Hayashi, Hiroko, Kobayashi, Kazuma, Adachi, Tomohiko, Hidaka, Masaaki, Itoh, Shinichiro, Kanetaka, Kengo, Eguchi, Susumu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424078/
https://www.ncbi.nlm.nih.gov/pubmed/35022341
http://dx.doi.org/10.2169/internalmedicine.7786-21
_version_ 1784778161323507712
author Kawaguchi, Yuta
Kuba, Sayaka
Morita, Michi
Meng, Xiangyue
Hayashi, Hiroko
Kobayashi, Kazuma
Adachi, Tomohiko
Hidaka, Masaaki
Itoh, Shinichiro
Kanetaka, Kengo
Eguchi, Susumu
author_facet Kawaguchi, Yuta
Kuba, Sayaka
Morita, Michi
Meng, Xiangyue
Hayashi, Hiroko
Kobayashi, Kazuma
Adachi, Tomohiko
Hidaka, Masaaki
Itoh, Shinichiro
Kanetaka, Kengo
Eguchi, Susumu
author_sort Kawaguchi, Yuta
collection PubMed
description A 66-year-old woman underwent partial mastectomy and a sentinel lymph node biopsy for left breast cancer; the pathological diagnosis was invasive ductal carcinoma (pT1aN0, pStage I, triple-negative subtype). Postoperative radiotherapy was performed. Two years later, she developed redness and induration at both breasts. The diagnosis was bilateral inflammatory breast cancer. After four cycles of dose-dense epirubicin and cyclophosphamide followed by 12 weekly paclitaxel cycles, bilateral total mastectomy and axillary lymph node dissection were performed. At the one-year follow-up after undergoing operation and radiotherapy, she remained alive without recurrence. Dose-dense treatment regimens may help patients achieve complete resection without short-term recurrence.
format Online
Article
Text
id pubmed-9424078
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-94240782022-09-15 Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer Kawaguchi, Yuta Kuba, Sayaka Morita, Michi Meng, Xiangyue Hayashi, Hiroko Kobayashi, Kazuma Adachi, Tomohiko Hidaka, Masaaki Itoh, Shinichiro Kanetaka, Kengo Eguchi, Susumu Intern Med Case Report A 66-year-old woman underwent partial mastectomy and a sentinel lymph node biopsy for left breast cancer; the pathological diagnosis was invasive ductal carcinoma (pT1aN0, pStage I, triple-negative subtype). Postoperative radiotherapy was performed. Two years later, she developed redness and induration at both breasts. The diagnosis was bilateral inflammatory breast cancer. After four cycles of dose-dense epirubicin and cyclophosphamide followed by 12 weekly paclitaxel cycles, bilateral total mastectomy and axillary lymph node dissection were performed. At the one-year follow-up after undergoing operation and radiotherapy, she remained alive without recurrence. Dose-dense treatment regimens may help patients achieve complete resection without short-term recurrence. The Japanese Society of Internal Medicine 2022-01-13 2022-08-01 /pmc/articles/PMC9424078/ /pubmed/35022341 http://dx.doi.org/10.2169/internalmedicine.7786-21 Text en Copyright © 2022 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Kawaguchi, Yuta
Kuba, Sayaka
Morita, Michi
Meng, Xiangyue
Hayashi, Hiroko
Kobayashi, Kazuma
Adachi, Tomohiko
Hidaka, Masaaki
Itoh, Shinichiro
Kanetaka, Kengo
Eguchi, Susumu
Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer
title Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer
title_full Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer
title_fullStr Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer
title_full_unstemmed Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer
title_short Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer
title_sort bilateral inflammatory breast cancer that developed two years after treatment for triple-negative breast cancer
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424078/
https://www.ncbi.nlm.nih.gov/pubmed/35022341
http://dx.doi.org/10.2169/internalmedicine.7786-21
work_keys_str_mv AT kawaguchiyuta bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer
AT kubasayaka bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer
AT moritamichi bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer
AT mengxiangyue bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer
AT hayashihiroko bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer
AT kobayashikazuma bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer
AT adachitomohiko bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer
AT hidakamasaaki bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer
AT itohshinichiro bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer
AT kanetakakengo bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer
AT eguchisusumu bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer